Canaccord Boosts PT on Incyte (INCY) to $85; Sees Plenty of Positive Events in 2014
Tweet Send to a Friend
Canaccord Genuity boosts its price target on Incyte (Nasdaq: INCY) from $79 up to $85, while maintaining a Buy rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
